These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066 [TBL] [Abstract][Full Text] [Related]
10. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease]. Arahata Y; Kato T; Tadokoro M; Sobue G Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454 [TBL] [Abstract][Full Text] [Related]
11. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample. Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687 [TBL] [Abstract][Full Text] [Related]
12. [Cerebral glucose metabolism in Parkinson's disease with dementia]. Ma AJ; Zhang BS; Pan XD; Gao S; Li ZG Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2623-8. PubMed ID: 19080710 [TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Antonini A; Kazumata K; Feigin A; Mandel F; Dhawan V; Margouleff C; Eidelberg D Mov Disord; 1998 Mar; 13(2):268-74. PubMed ID: 9539340 [TBL] [Abstract][Full Text] [Related]
15. The metabolic anatomy of tremor in Parkinson's disease. Antonini A; Moeller JR; Nakamura T; Spetsieris P; Dhawan V; Eidelberg D Neurology; 1998 Sep; 51(3):803-10. PubMed ID: 9748030 [TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107 [TBL] [Abstract][Full Text] [Related]
18. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing. Moeller JR; Eidelberg D Brain; 1997 Dec; 120 ( Pt 12)():2197-206. PubMed ID: 9448575 [TBL] [Abstract][Full Text] [Related]
19. The use of PET in Parkinson's disease. Shinotoh H; Calne DB Brain Cogn; 1995 Aug; 28(3):297-310. PubMed ID: 8546856 [TBL] [Abstract][Full Text] [Related]
20. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Berding G; Odin P; Brooks DJ; Nikkhah G; Matthies C; Peschel T; Shing M; Kolbe H; van Den Hoff J; Fricke H; Dengler R; Samii M; Knapp WH Mov Disord; 2001 Nov; 16(6):1014-22. PubMed ID: 11748732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]